School of Medicine


Showing 1-10 of 11 Results

  • Guido Davidzon

    Guido Davidzon

    Clinical Assistant Professor, Radiology - Rad/Nuclear Medicine

    Bio Dr. Guido A. Davidzon is a physician-scientist board certified in Nuclear Medicine. He is an attending physician in Nuclear Medicine and Molecular Imaging at Stanford Health Care.

    He graduated with honors from medical school in Argentina and completed an internship at Yale University New-Haven Hospital in Connecticut. He did his residency and was chief resident at Stanford Health Care. He completed a research fellowship in mitochondrial diseases at Columbia University in New York and, a U.S. National Library of Medicine Award supported, Biomedical Informatics fellowship at Massachusetts General Hospital in conjunction with a Science Masters at MIT.

    Dr. Davidzon is Clinical Assistant Professor in the Department of Radiology at Stanford University. His clinical specialties include early diagnostic imaging of cancer, coronary artery disease, and dementias using molecular probes as well as the treatment of cancer for which he employs targeted radiopharmaceutical therapy.

    Dr. Davidzon investigates the use of machine learning in medical imaging to improve clinical outcomes, he is involved in the professional Society of Nuclear Medicine and Molecular Imaging. He serves as a peer reviewer for multiple medical journals. Dr. Davidzon is a native of Buenos Aires, Argentina and has lived in the U.S. for over a decade. He travels to Argentina frequently, with his wife and three sons.

  • Benjamin Lewis Franc

    Benjamin Lewis Franc

    Clinical Professor, Radiology - Rad/Nuclear Medicine

    Bio Dr. Franc has over 15 years of experience in clinical nuclear medicine with particular expertise in PET-CT. He publishes and lectures predominantly on applications and innovations of PET-CT. As a clinical leader, Dr. Franc has developed programs for the early adoption and implementation of nuclear-based imaging and therapeutic technologies including combined positron emission tomography (PET) and computed tomography (CT) (combined PET-CT) and combined single photon emission computed tomography and CT (SPECT-CT) for quantitative oncologic and cardiac applications. Dr. Franc has experience in all aspects of PET radiopharmaceutical development, spanning the design of molecules, synthesis of radioligands, and use in animal and human imaging. He also has expertise in quantitative image analysis, development of novel post-processing image reconstruction methods, and the application of artificial intelligence in human diagnostics. Along with radiochemistry and radiopharmacy colleagues at the UCSF Cyclotron Facility, Dr. Franc has implemented new radiopharmaceuticals in pre-clinical and clinical research PET imaging as well as for clinical PET with applications in cancer, infectious disease (HIV), and autoimmune disease (RA).

    In addition to translational science and clinical research, Dr. Franc has established himself in the area of health policy. His research, publications, and lectures in health policy focus on improving value of healthcare through decrease in variability and implementation of precision health techniques into the clinic.

  • Kristina Elizabeth Hoque

    Kristina Elizabeth Hoque

    Clinical Instructor, Radiology - Rad/Nuclear Medicine

    Bio Kristina Elizabeth Hawk, MS MD PhD is a Nuclear Medicine Physician and Neuroradiologist. As a physician scientist, integrated MD/PhD training helped build a foundation to explore translational research efforts, using a full and intricate understanding of the research process, and the developed ability to understand, discuss and teach new emerging concepts. Dr. Hawk?s dissertation in Neuroscience focused on the regulation of Nitric Oxide Synthase in the dorsal and ventral striatum, exploring the neurochemical role of nitric oxide producing interneurons, and their ability to coordinate dopaminergic and glutamatergic signaling in areas of the brain relevant to cognition and motivated behavior.

    Eager to expand her passion into the field of Medical Radiation Physics, she also completed a separate Masters degree in Medical Radiation Physics. This provided her with in depth training of how therapeutic and diagnostic instruments use both ionizing and non-ionizing radiation in the clinical setting. She then completed her Medical Doctorate and Diagnostic Radiology Residency at the University of Southern California (USC), learning the art of medicine while serving the diverse population at Los Angeles County Hospital.

    Dr. Hawk completed clinical fellowship requirements in Nuclear Medicine at USC, and is now Board Certified by the American Board of Nuclear Medicine. She also completed a Neuroradiology fellowship at USC, and is Board Certified the American Board of Radiology. She served as both the Chief Resident and Chief Neuroradiology Fellow.

    Dr. Hawk has held multiple local and national leadership positions, including positions in the American College of Radiology (ACR), the American College of Nuclear Medicine (ACNM) and the Society of Nuclear and Molecular Medicine (SNMMI). Dr. Hawk is an editorial board member of the Journal of the American College of Radiology (JACR). She has served as the Vice-Chair for Education for the Nuclear Medicine Resident Organization of the ACNM, and the Educational Liaison for the Resident and Fellow Section of the ACR. Currently, she serves on the national ACR Commission for Women and General Diversity as well as the ACR Commission on Nuclear Medicine. Dr. Hawk also sits on the ACR Council Steering Committee.

    Dr. Hawk is committed to continually exploring the beautiful applications of ionizing and non-ionizing radiation to image and treat the human body.

  • Andrei Iagaru

    Andrei Iagaru

    Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center

    Current Research and Scholarly Interests Current research projects include:
    1) PET/MRI and PET/CT for Early Cancer Detection
    2) Targeted Radionuclide Therapy
    3) Clinical Translation of Novel PET Radiopharmaceuticals;

Footer Links:

Stanford Medicine Resources: